Martek Biosciences Corp. (MATK)
Develops and commercializes products derived from microalgae, fungi and other microbes. Products are nutritional oils used as ingredients in infant formula and foods, and as ingredients in and encapsulated for use as dietary supplements.
Recs
Just a hunch!!!
Recs
Stranglehold on non-fish DHA. This supplment has a no. of proven health benefits. Gauranteed income at current valuation for the next 5-10 years from baby supplements. All the rest is gravy.
Recs
My favorite low-cost biotech. Their supplements will soon be in everything from baby formula to senior nutrition drinks. Columbia, MD company makes money and is bargain-priced. Also ripe for a takeover by a big PhRMA or food company.
Recs
DHA powder is too expensive to be acepted by food manufacturers. DHA oil is not stable enough to be used in most food applications. Martek's oil will perform only as a niche product in some vegetarian foods.
Recs
With China as a prospect and better earnings this non tech stock seems primed to move further. It's chart is just completing a W and looks to break out soon although there is always the chance it needs more consolidation. Health food products are in demand today. i myself buy quite a bit of stuff although I'm not a big fan of powdered proteins. Still I think with many people running and pedaling, the demand will rise. When I started running 35 years ago hardly anyone ran. Now - it's the premium exercise. Almost free and products surrounding exercise seem a good bet.
Recs
Consistant Development
Recs
IT WILL BE A TAKEOVER TARGET AT THESE LEVELS AS IS MARKETING NEW PRODUCTS AND TYING WITH FEW LARGE COMPANY WITH THEIR PRODUCTS
Recs
Forming new trend. Not necessaryily one that can be held more than a few months, but the trend never seems to hold. But they are in a very interesting business.
Recs
Although the fish source is better for you (you need EPA as much as DHA but this is another story all together)--this pond scum nonsense will find its way into most every food...Limited nutritional benefit but plenty of profit benefit. Investing is all about perception....
Just not enough fish to go around--their scum product will BOOM!
Recs
Following the herd.
Recs
market timing
Recs
A monopoly in the DHA and ARA infant formula market. A growing food business. It has a book value of $15.35 and trades at $22. Just turned free cash flow positive and by next year will have a $1 per share free cash flow run rate. Insiders just bought shares under $22. Omega 3 fatty acids are the future for babies and the elderly. Some great research coming out on Omega 3's (cardiovascular, eye, alzheimer's etc)
Recs
Market for their oils is expanding beyond baby formula and should ramp up quickly. Stock is oversold and near support at 20.
Recs
Testing out a portfolio of smallish-cap 5-star stocks found using the CAPS screener. All picks have at least 50 allstars backing them, which should be enough to minimize star rating fluctuations. It's been less than a week, but so far so good!
Recs
Yes - sound nutritonal science
Recs
Martek has only a handful of customers for its baby formula makings which makes its orders come in choppy. Can't follow this month-to-month, have to view financials on a much longer cycle. Stock is down now, but will recover nicely with strong insider ownership committed to its success.
Recs
Proven great product. Just needs time to work out distrubition.
Recs
Hop on this roller coaster...
Recs
All 28 picks #8+ , initiated on 5/18/08, are CAPS 5 star rated, were pos on 5/16/08, have consistant gains YTD, and are among the holdings of the five top CAPS rated players.
Recs
unique position in nutrient aids. several new customers coming on board

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 54 1 2 3 Next »